Characteristics and Cardiovascular Disease Event Rates among African Americans and Whites Who Meet the Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk (FOURIER) Trial Inclusion Criteria

Title : Characteristics and Cardiovascular Disease Event Rates among African Americans and Whites Who Meet the Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk (FOURIER) Trial Inclusion Criteria

Source : Cochrane
ID : 30746585
Authors : Lisandro D. Colantonio & Keri L. Monda & Robert S. Rosenson & Todd M. Brown & Katherine E. Mues & George Howard & Monika M. Safford & Larisa Yedigarova & Michael E. Farkouh8 & Paul Muntner
Year : 2019
Disease Category : Cardiovascular diseases
Focused Population : Not Specified
Priori/Posteriori : Posteriori
Single-study Generalibility? : Single
Score/Non-Score : Non-score
Tutorial/Method : NHANES_T2D
Compared general demographic and patient characteristics : Yes
Compared disease-specific clinical characteristics : Yes
Compared adverse events : No
Compared outcomes/treatment effect (including survival) : Yes
Trial participants vs. eligible patients (by applying eligibility criteria on the patient data) : Yes
Real-world data sources : REGARDS participants who meet FOURIER criteria
Target Population Data Type Levels : Trial